beauty

Crystal Lake, Illinois, December 20, 2022 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its VP7 nasal multidose device is the delivery system for Hibiocy’s VAILL COVITRAP™ Anti-CoV nasal spray, which was recently approved by the Thailand Food and Drug Administration (FDA).

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, recently announced the construction of a new facility in India at a ceremony to also celebrate Aptar Mumbai’s ten year anniversary. 

Company’s groundbreaking mono-material barrier tube becomes first tube/cap combination successfully tested by EU-based cross-industry initiative, which promotes increased recycling and plastics circularity.

Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider of high-quality packaging for pharma, beauty and oral care, has been granted RecyClass approval for its Polyfoil® MMB mono-material barrier tube, a groundbreaking combination of product protection, user friendliness and appealing aesthetics.  

Company’s Stylo™ Pipette Tube for Filorga takes ‘Laminates’ category; new mono-material barrier tube, Polyfoil® MMB, named best Prototype.

Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider of high-quality packaging for pharma, beauty and oral care, has won two awards from the European Tube Manufacturers Association (ETMA). One accolade recognized a current customer application, the other a groundbreaking sustainability solution on the verge of market launch.

 Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), for the development of a new connected drug delivery device and companion mobile app, the first of its kind, for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions.

Crystal Lake, Illinois and Cardiff, United Kingdom, October 21, 2021 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for the development of pharmaceutical formulations, today announced an exclusive partnership to co-develop and promote i2c’s patented pressurized metered dose inhaler (pMDI) technology, Respitab.

Proven to meet e-Commerce robustness standards and preferred by consumers, SeaWell™ systems maintain seafood quality, freshness and aesthetics during direct-to-consumer delivery.

The BlueLight collection is a digital-detox product line that prevents and protects skin from the harmful effects of blue light; the TwiLight collection is a synesthetic collection of supercharged overnight skincare products that awake the senses, transform moods and provide a relaxing experience.

Crystal Lake, Illinois, January 14, 2021 - AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is February 17, 2021, to stockholders of record as of January 27, 2021.